发明授权
US09080220B2 Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative
有权
至少一种肉毒杆菌神经毒素和至少一种阿片衍生物的同时，单独或连续的治疗用途
- 专利标题： Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative
- 专利标题（中）： 至少一种肉毒杆菌神经毒素和至少一种阿片衍生物的同时，单独或连续的治疗用途
-
申请号： US12305191申请日： 2007-06-11
-
公开(公告)号： US09080220B2公开(公告)日： 2015-07-14
- 发明人: Michel Auguet , Christine Favre , Pierre-Etienne Chabrier De Lassauniere
- 申请人： Michel Auguet , Christine Favre , Pierre-Etienne Chabrier De Lassauniere
- 申请人地址： FR Boulogne-Billancourt
- 专利权人： IPSEN PHARMA S.A.S.
- 当前专利权人： IPSEN PHARMA S.A.S.
- 当前专利权人地址： FR Boulogne-Billancourt
- 代理机构： Hunton & Williams LLP
- 优先权： FR0605368 20060616
- 国际申请： PCT/FR2007/000956 WO 20070611
- 国际公布： WO2007/144493 WO 20071221
- 主分类号： A61K38/48
- IPC分类号： A61K38/48 ; A61K39/08 ; A61K9/00 ; A61K31/485 ; A61K45/06
摘要：
The present invention relates to a composition comprising: at least one botulinum neurotoxin, and at least one opiate derivative or its salt. The invention also relates to a product comprising at least one botulinum neurotoxin and at least one opiate derivative or its salt, as a combination product for simultaneous, separate or sequential therapeutic use in the treatment or prevention of pain and of neuromuscular disorders.
公开/授权文献
信息查询
IPC分类:
